Yvonne E. Ang
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges.
Journal: Expert review of anticancer therapy
Published: February 08, 2026
Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 17, 2025
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: April 14, 2025
Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.
Journal: The Lancet regional health. Western Pacific
Published: March 20, 2025
Is Gamma Knife surgery, omitting adjunct whole brain radiation treatment, feasible for patients with 20 or more brain metastases?
Journal: Neuro-oncology advances
Published: June 14, 2024
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 19, 2024
Has the Ship Sailed on Second-Generation ALK Tyrosine Kinase Inhibitors in the Post-Crizotinib Setting?
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 12, 2023
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study).
Journal: Cancers
Published: August 10, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 21, 2023
Effect of perioperative seizures on mortality and recurrence in patients with brain metastases.
Journal: Frontiers in oncology
Published: September 19, 2022
Last Updated: 09/26/2026